RMD Q4 2025 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena

RMDResMed Inc.

$36B

Q4 2025 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$1.3B+10.2% YoY

Gross Profit

$820M60.8% margin

Operating Income

$455M33.7% margin

Net Income

$380M28.2% margin

EPS (Diluted)

$2.58

QoQ Revenue Growth

+4.4%

Cash Flow

Operating Cash Flow

$539M

Free Cash Flow

$508M

Stock-Based Comp.

$25M

Balance Sheet

Total Assets

$8.2B

Total Liabilities

$2.2B

Stockholders' Equity

$6.0B

Cash & Equivalents

$1.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.3B	$1.2B	+10.2%
Gross Profit	$820M	$704M	+16.4%
Operating Income	$455M	$381M	+19.2%
Net Income	$380M	$292M	+29.9%